Expert opinion on the treatment of patients with chronic hepatitis C

The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24–48 weeks. Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeuzem, S, Berg, T, Moeller, B, Hinrichsen, H, Mauss, S, Wedemeyer, H, Sarrazin, C, Hueppe, D, Zehnter, E, Manns, M P
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759987/
https://www.ncbi.nlm.nih.gov/pubmed/18761607
http://dx.doi.org/10.1111/j.1365-2893.2008.01012.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759987/
https://www.ncbi.nlm.nih.gov/pubmed/18761607
http://dx.doi.org/10.1111/j.1365-2893.2008.01012.x

Ejemplares similares